Reports: ZORA Program (Slovenia): Difference between revisions

From Beacon
No edit summary
No edit summary
Line 6: Line 6:
'''Sponsor, manager or home institution:''' [[dataOwner::Ljubljana Oncology Institute]]; [[dataOwner::ZORA Program]].  
'''Sponsor, manager or home institution:''' [[dataOwner::Ljubljana Oncology Institute]]; [[dataOwner::ZORA Program]].  


'''Type of information:''' The percentage of women in the target group who are screened according to the program guidelines (screening); The number of new patients in a given year; (RMV incidence rate); Mortality due to RMV; The ratio between the number of newly detected precancerous and cancerous changes per year. [https://zora.onko-i.si/publikacije/letna-porocila Click here to learn more].
'''Type of information:''' The percentage of women in the target group who are screened according to the program guidelines ([[availableVariable::screening]]); The number of new patients in a given year; (RMV [[availableVariable::cancer incidence|incidence]] rate); [[availableVariable::number of deaths|Mortality]] due to RMV; [[availableVariable::causes of death]]; The ratio between the number of newly detected precancerous and cancerous changes per [[availableVariable::year]]. [https://zora.onko-i.si/publikacije/letna-porocila Click here to learn more].


'''Data level:''' [[dataLevel::national level]].
'''Data level:''' [[dataLevel::national level]].

Revision as of 12:20, 17 June 2024

Go back to Slovenia page

Primary purpose: To actively screen and reduce morbidity and mortality from cervical cancer in Slovenia, aiming for at least 70% coverage of women aged 20-64 through regular cervical smear examinations every three years.

Sponsor, manager or home institution: Ljubljana Oncology Institute; ZORA Program.

Type of information: The percentage of women in the target group who are screened according to the program guidelines (screening); The number of new patients in a given year; (RMV incidence rate); Mortality due to RMV; causes of death; The ratio between the number of newly detected precancerous and cancerous changes per year. Click here to learn more.

Data level: national level.

Cancer areas of interest: C51-C58: Female genitalia cancer. Click here to learn more.

Access to information: Click here to access.